Animal testing is costly and there is a great deal of research on finding viable and effective alternatives (new methods that refine existing tests by minimizing animal distress, reducing animal usage, or replacing whole animal tests). Despite large reductions in animal testing since the early 1980s due to improved in vitro methods, levels remain high (over 3 million procedures in 2006) and results cannot always be extrapolated to humans.
The application of nanotechnology is currently revolutionizing medicine and this two-day conference, the first of its kind in Europe, will examine the role nanotechnology could also play in improving or refining the development of alternatives to animal testing whilst maintaining safety.
Themes will include:
· a review of some of the most promising human cell-based in vitro models
· novel lab-on-a-chip and bioreactor systems for screening, toxicology and targeting studies
· surface modification at the nanoscale to improve biosensors and in vitro test systems
· potential new strategies for applying nanotechnology to alternatives
· the role of the European Centre for the Validation of Alternative Methods (ECVAM)
The conference will be of particular interest to those involved in:
· pharmaceutical, medical device and cosmetic development and testing
· environmental and food testing
· regulation
· organizations interested in the development of animal alternatives.
For online registration and payment visit https://www.nano.org.uk/payments/index.php.
Further abstracts are welcomed for oral or poster presentations by 26 November 2007, please contact carrie.smith@nano.org.uk.
Standard Delegate - £500; Academic/IoN Member - £450;
Exhibitor (incl. one delegate) - £750; Additional delegate - £350
Visit www.nano.org.uk/events/ionevents.htm for regular updates on the event.
Fax to: 01786 447530 or contact Carrie Smith Tel: +44 (0)1786 447520
Registered charity no. SC 025709
No comments:
Post a Comment